Abstract
The use of chemical warfare agents is of serious concern for the military and civilian populations. The experience of the twentieth and twenty-first centuries reveals that nerve agents and mustard gas are the main chemicals used for mass destruction. The vesicating effect of mustard gas is the main focus of this review. Its powerful irritating activities in the dermal, pulmonary and ocular systems stem from alkylation of macromolecules and induction of inflammatory response and oxidative stress. This review describes the pathological processes occurring upon exposure to mustard gas and the molecular and cellular events leading to its devastating health effects. Based on its mechanism of action, a series of potential antidotes and their combinations was proposed as countermeasures for mustard gas toxicity. In spite of the intensive research and information on this vesicant, much effort is needed for further elucidation of its mode of action and improvement of antidotal activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Saladi RN, Smith E, Persaud AN (2006) Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol 31(1):1–5
Balali Mood M, Hefazi M (2005) The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19(3):297–315
Wormser U (1991) Toxicology of mustard gas. Trends Pharmacol Sci 12(4):164–167
Somani SM, Babu SR (1989) Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 27(9):419–435
Graham JS, Schoneboom BA (2013) Historical perspective on effects and treatment of sulfur mustard injuries. Chem Biol Interact 206(3):512–522
Aasted A, Darre E, Wulf HC (1987) Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg 19(4):330–333
Wulf HC, Aasted A, Darre E, Niebuhr E (1985) Sister chromatid exchanges in fishermen exposed to leaking mustard gas shells. Lancet 1(8430):690–691
Davis KG, Aspera G (2001) Exposure to liquid sulfur mustard. Ann Emerg Med 37(6):653–656
Newmark J, Langer JM, Capacio B, Barr J, McIntosh RG (2007) Liquid sulfur mustard exposure. Mil Med 172(2):196–198
Weibrecht K, Rhyee S, Manuell ME, Longo C, Boyer EW, Brush E (2012) Sulfur mustard exposure presenting to a community emergency department. Ann Emerg Med 59(1):70–74
Tu AT (2007) Toxicological and chemical aspects of sarin terrorism in Japan in 1994 and 1995. Toxin Rev 26(3):231–274
Yokoyama K (2007) Our recent experiences with sarin poisoning cases in Japan and pesticide users with references to some selected chemicals. NeuroToxicology 28(2):364–373
Yanagisawa N, Morita H, Nakajima T (2006) Sarin experiences in Japan: Acute toxicity and long-term effects. J Neurol Sci 249(1):76–85
Nakajima T, Ohta S, Fukushima Y, Yanagisawa N (1999) Sequelae of sarin toxicity at one and three years after exposure in Matsumoto Japan. J Epidemiol 9(5):337–343
Solberg Y, Nachtomi-Shick O, Shemer Y, Alcalay M (1998) Terror in Japan: mass-intoxication with the nerve-agent sarin. Harefuah 135(7–8):268–271, 336, 335
Nakajima T, Ohta S, Morita H, Midorikawa Y, Mimura S, Yanagisawa N (1998) Epidemiological study of sarin poisoning in Matsumoto city Japan. J Epidemiol 8(1):33–41
Nakajima T, Sato S, Morita H, Yanagisawa N (1997) Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Occup Environ Med 54(10):697–701
Suzuki J, Kohno T, Tsukagosi M, Furuhata T, Yamazaki K (1997) Eighteen cases exposed to Sarin in Matsumoto Japan. intern Med 36(7):466–470
Morita H, Yanagisawa N, Nakajima T, Shimizu M, Hirabayashi H, Okudera H et al (1995) Sarin poisoning in Matsumoto, Japan. Lancet 346(8970):290–293
Gulland A (2013) Lack of atropine in Syria hampers treatment after gas attacks. BMJ 347:f5413
Chinthapalli K (2013) When a doctor goes wrong: Good and evil medical practice on the roads to Damascus. BMJ (Online) 347:f5455
Enserink M (2013) U.N. taps special labs to investigate Syrian attack. Science 341(6150):1050–1051
Laskin JD, Black AT, Jan YH, Sinko PJ, Heindel ND, Sunil V et al (2010) Oxidants and antioxidants in sulfur mustard-induced injury. Ann NY Acad Sci 1203:92–100
Willems JL (1989) Clinical management of mustard gas casualties. Medicinae Militaris Belgicae 3(Suppl):1–61
Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M (1992) Skin manifestations of mustard gas: a clinical study of 535 patients exposed to mustard gas. Arch Dermatol 128(6):775–780
Kehe K, Thiermann H, Balszuweit F, Eyer F, Steinritz D, Zilker T (2009) Acute effects of sulfur mustard injury-Munich experiences. Toxicology 263(1):3–8
Sinclair DC (1949) Treatment of skin lesions caused by mustard gas. Br Med J 1(4602):476–478
Sinclair DC (1949) The clinical reaction of the skin to mustard gas vapor. Br J Dermatol Syph 61:113–125
Sinclair DC (1950) Disability produced by exposure of skin to mustard-gas vapour. Br Med J 1(4649):346–349
Derby GS (1918) Effect of mustard gas on eyes. Am J Med Sci 156:733–736
Sohrabpour H (1987) Observation and clinical manifestations of patients injured with mustard gas. Med J Islamic Republic of Iran 1:32–37
Mandel M, Gibson WS (1917) Clinical manifestations and treatment of gas poisoning. JAMA 69:1970–1971
Hobbs FB (1944) Fatal case of mustard gas poisoning. Br Med J 2:306–307
IARC Monographs (1975) Mustard gas. 9, 181–192. WHO, Geneva
Easton DF, Peto J, Doll R (1988) Cancers of the respiratory tract in mustard gas workers. Br J Ind Med 45(10):652–659
Doi M, Hattori N, Yokoyama A, Onari Y, Kanehara M, Masuda K et al (2011) Effect of mustard gas exposure on incidence of lung cancer: a longitudinal study. Am J Epidemiol 173(6):659–666
Harb A, Sawyer AR, Pandya A (2013) Skin SCC following mustard gas testing in a British army recruit. Eur J Plast Surg 36(2):115–117
Blodi FC (1971) Mustard gas keratopathy. Int Ophthalmol Clin 11(3):1–13
Wheeler GP (1962) Studies related to the mechanisms of action of cytotoxic alkylating agents: a review. Cancer Res 22:651–688
Ball CR, Roberts JJ (1972) Estimation of interstrand DNA cross-linking resulting from mustard gas alkylation of HeLa cells. Chem Biol Interact 4(4):297–303
Walker IG (1971) Intrastrand bifunctional alkylation of DNA in mammalian cells treated with mustard gas. Can J Biochem 49(3):332–336
Ludlum DB, Kent S, Mehta JR (1986) Formation of O6-ethylthioethylguanine in DNA by reaction with the sulfur mustard, chloroethyl sulfide, and its apparent lack of repair by O6-alkylguanine DNA alkyltransferase. Carcinogenesis 7(7):1203–1206
Kircher M, Brendel M (1983) DNA alkylation by mustard gas in yeast strains of different repair capacity. Chem Biol Interact 44(1–2):27–39
Savage JRK, Breckon G (1981) Different effects of sulphur mustard on S-phase cells of primary fibroblast cultures from Syrian hamsters. Mutat Res 84(2):375–387
Roberts JJ, Friedlos F, Scott D (1986) The unique sensitivity of Walker rat tumour cells to difunctional agents is associated with a failure to recover from inhibition of DNA synthesis and increased chromosome damage. Mutat Res 166(2):169–181
Wormser U, Brodsky B, Green BS, rad Yellin R, Nyska A (1997) Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch Toxicol 71(3):165–170
Wormser U, Sintov A, Brodsky B, Nyska A (2000) Topical iodine preparation as therapy against sulfur mustard-induced skin lesions. Toxicol Appl Pharmacol 169(1):33–39
Wormser U, Sintov A, Brodsky B, Amitai Y, Nyska A (2002) Protective effect of topical iodine preparations upon heat-induced and hydrofluoric acid-induced skin lesions. Toxicol Pathol 30(5):552–558
Mishra NC, Rir-sima-ah J, March T, Weber W, Benson J, Jaramillo R et al (2010) Sulfur mustard induces immune sensitization in hairless guinea pigs. Int Immunopharmacol 10(2):193–199
Wormser U, Brodsky B, Proscura E, Foley JF, Jones T, Nyska A (2005) Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion; effect of topical iodine. Arch Toxicol 79(11):660–670
Mouret S, Wartelle J, Clery-Barraud C, Emorine S, Bertoni M, El BN et al (2012) Cutaneous toxicity of sulfur mustard and inflammatory biomarkers of exposure in SKH-1 hairless mouse skin. J Invest Dermatol 132:S25
Vallet V, Poyot T, Clery-Barraud C, Coulon D, Sentenac C, Peinnequin A et al (2011) Acute and long-term transcriptional responses in sulfur mustard-exposed SKH-1 hairless mouse skin. Cutaneous Ocul Toxicol 31(1):38–47
Sekharam M, Cunnick JM, Wu J (2000) Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes. Biochem J 346:751–758
Balszuweit F, Schmidt A, John H, Kehe K, Thiermann H, Steinritz D (2013) Silibinin as a potential therapeutic for sulfur mustard injuries. Naunyn-Schmiedeberg’s Arch Pharmacol 386:S6
Liu H-Y, Shi H-N, Ying Y, Liu Y-Q, Guo J-Y, Wang Y-W et al (2011) Inhibition of serine protease inhibitor SPI-I on sulfur mustard-induced cutaneous inflammation. J Int Pharm Res 38(6):452–456
Yego ECK, Dillman JF (2013) Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard. Toxicol In Vitro 27(7):2067–2075
Dachir S, Cohen M, Kamus-Elimeleh D, Fishbine E, Sahar R, Gez R et al (2012) Characterization of acute and long-term pathologies of superficial and deep dermal sulfur mustard skin lesions in the hairless guinea pig model. Wound Repair Regen 20(6):852–861
Dachir S, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Amir A et al (2004) Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J Appl Toxicol 24(2):107–113
Wormser U, Brodsky B, Reich R (2002) Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity. Arch Toxicol 76(2):119–121
Kohen R (1999) Skin antioxidants: Their role in aging and in oxidative stress – New approaches for their evaluation. Biomed Pharmacother 53(4):181–192
Laskin JD, Black AT, Jan YH, Sinko PJ, Heindel ND, Sunil V et al (2010) Oxidants and antioxidants in sulfur mustard-induced injury. Ann NY Acad Sci 1203(1):92–100
Pal A, Tewari-Singh N, Gu M, Agarwal C, Huang J, Day BJ et al (2009) Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice. Free Radic Biol Med 47(11):1640–1651
Kumar O, Sugendran K, Vijayaraghavan R (2001) Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact 134(1):1–12
Shohrati M, Ghanei M, Shamspour N, Babaei F, Abadi MN, Jafari M et al (2010) Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188(1):77–83
Elsayed NM, Omaye ST, Klain GJ, Inase JL, Dahlberg ET, Wheeler CR et al (1989) Response of mouse brain to a single subcutaneous injection of the monofunctional sulfur mustard, butyl 2-chloroethyl sulfide (BCS). Toxicology 58(1):11–20
Pohanka M, Stetina R, Svobodova H, Ruttkay-Nedecky B, Jilkova M, Sochor J et al (2012) Sulfur mustard causes oxidative stress and depletion of antioxidants in muscles, livers, and kidneys of Wistar rats. Drug Chem Toxicol 36(3):270–276
Tang FR, Loke WK (2012) Sulfur mustard and respiratory diseases. Crit Rev Toxicol 42(8):688–702
McClintock SD, Hoesel LM, Das SK, Till GO, Neff T, Kunkel RG et al (2006) Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 26(2):126–131
McClintock SD, Till GO, Smith MG, Ward PA (2002) Protection from half-mustard-gas-induced acute lung injury in the rat. J Appl Toxicol 22(4):257–262
Lu SC (2009) Regulation of glutathione synthesis. Mol Aspects Med 30(1–2):42–59
Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47(1):89–116
Abel EL, Bubel JD, Simper MS, Powell L, McClellan SA, Andreeff M et al (2011) Protection against 2-chloroethyl ethyl sulfide (CEES) – induced cytotoxicity in human keratinocytes by an inducer of the glutathione detoxification pathway. Toxicol Appl Pharmacol 255(2):176–183
Abel EL, Boulware S, Fields T, McIvor E, Powell KL, DiGiovanni J et al (2013) Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog. Toxicol Appl Pharmacol 266(3):439–442
Sakurai A, Nishimoto M, Himeno S, Imura N, Tsujimoto M, Kunimoto M et al (2005) Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: Role of NF-E2-related factor-2. J Cell Physiol 203(3):529–537
Jan YH, Heck DE, Gray JP, Zheng H, Casillas RP, Laskin DL et al (2010) Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells. Chem Res Toxicol 23(6):1045–1053
Nyska A, Lomnitski L, Maronpot R, Moomaw C, Brodsky B, Sintov A et al (2001) Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin injury in guinea pigs. Arch Toxicol 74(12):768–774
Qui M, Paromov V, Yang H, Smith M, Stone W (2006) Inhibition of inducible Nitric Oxide Synthase by a mustard gas analog in murine macrophages. BMC Cell Biol 7(1):39
Steinritz D, Elischer A, Balszuweit F, Gonder S, Heinrich A, Bloch W et al (2009) Sulphur mustard induces time- and concentration-dependent regulation of NO-synthesizing enzymes. Toxicol Lett 188(3):263–269
Ucar M, Korkmaz A, Reiter RJ, Yaren H, Oter S, Kurt B et al (2007) Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 173(2):124–131
Yaren H, Mollaoglu H, Kurt B, Korkmaz A, Oter S, Topal T et al (2007) Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci 83(1):116–122
Sawyer TW, Risk D (2000) Effects of selected arginine analogues on sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes. Toxicol Appl Pharmacol 163(1):75–85
Sawyer TW (1999) Synergistic protective effects of selected arginine analogues against sulphur mustard toxicity in neuron culture. Toxicol Appl Pharmacol 155(2):169–176
Sawyer TW (1998) Modulation of sulfur mustard toxicity by arginine analogues and related nitric oxide synthase inhibitors in vitro. Toxicol Sci 46(1):112–123
Smith WJ (2009) Therapeutic options to treat sulfur mustard poisoning-the road ahead. Toxicology 263(1):70–73
Wormser U (1998) Early topical treatment with povidone-iodine ointment reduces, and sometimes prevents, skin damage following heat stimulus. Burns 24(4):383
Brodsky B, Wormser U (2007) Protection from toxicants. Curr Probl Dermatol 34:76–86
Brodsky B, Erlanger-Rosengarten A, Proscura E, Shapira E, Wormser U (2008) From topical antidote against skin irritants to a novel counter-irritating and anti-inflammatory peptide. Toxicol Appl Pharmacol 229(3):342–350
Acknowledgements
This work was supported in part by the US-Israel Binational Science Foundation grant no. 2007214 and Israel Science Foundation grant no. 1563/13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wormser, U., Finkelstein, Y., Proscura, E., Brodsky, B., Aschner, M. (2015). Chemical Warfare Agents. In: Roberts, S., Kehrer, J., Klotz, LO. (eds) Studies on Experimental Toxicology and Pharmacology. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Cham. https://doi.org/10.1007/978-3-319-19096-9_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-19096-9_19
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-19095-2
Online ISBN: 978-3-319-19096-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)